Essentials of SGLT2 Inhibitors in Diabetes

A modern class of medication used to manage type 2 diabetes. The authors begin by detailing the global health crisis of diabetes, noting its rising prevalence, diagnostic criteria, and the complex physiological mechanisms involving insulin resistance and beta-cell failure. A significant portion of the material explains how SGLT2 inhibitors function by blocking glucose reabsorption in the kidneys, which effectively lowers blood sugar while promoting weight loss and reducing blood pressure. The sources summarize extensive Phase III clinical trials for major drugs in this category, specifically dapagliflozin, canagliflozin, and empagliflozin, to demonstrate their effectiveness across various patient populations. Finally, the text addresses critical safety considerations, including potential side effects like genital infections, volume depletion, and the rare risk of euglycemic ketoacidosis.Get the Book now from Amazon:https://www.amazon.com/Essentials-SGLT2-Inhibitors-Diabetes-Fisher/dp/331943294X?&linkCode=ll2&tag=cvthunderx-20&linkId=66e3346ff8d601464c9b697346c7e489&language=en_US&ref_=as_li_ss_tlYou can listen and download our episodes for free on more than 10 different platforms:https://linktr.ee/pharmacy_simpleProduced by:https://www.podcaistudio.com/